Trade

Sai Life Sciences share price

Balanced risk
  • 39%Low risk
  • 39%Moderate risk
  • 39%Balanced risk
  • 39%High risk
  • 39%Extreme risk
  • 1,218.90(3.27%)
    June 12, 2026 15:40:24 PM IST
    • NSE
    • BSE
  • Vol : 350.23 K (NSE + BSE)
    Last 20 day avg : 974.91 K

Sai Life Sciences is trading 3.27% upper at Rs 1,218.90 as compared to its last closing price. Sai Life Sciences has been trading in the price range of 1,243.00 & 1,184.65. Sai Life Sciences has given 30.03% in this year & 1.89% in the last 5 days. There are 4 analysts who have initiated coverage on Sai Life Sciences. There are 2 analysts who have given it a strong buy rating & 2 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 104.24 Crores in its last quarter.Listed peers of Sai Life Sciences include Sun Pharmaceutical Industries (0.72%), Torrent Pharmaceuticals (0.15%), Divi's Laboratories (-0.34%).The Mutual Fund holding in Sai Life Sciences was at 27.80% in 31 Mar 2026. The MF holding has increased from the last quarter. The FII holding in Sai Life Sciences was at 21.17% in 31 Mar 2026. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Jun 13, 2026, 09:13 PM UTC

  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    0.32
    Indicates undervaluation
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    -
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    -
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    -
Price range
Day Range
Lowest
1,184.65
Highest
1,243.00
52 week range
Lowest
704.45
Highest
1,239.35
Sai Life Sciences Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Sun Pharmaceutical Industries
Bullish
1,807.250.724,32,524.8536.245.770.920.50
Torrent Pharmaceuticals
Bullish
4,577.000.151,54,232.0367.3217.10.8317.62
Divi's Laboratories
Bullish
6,628.80-0.341,75,426.5378.6100.460.01
Dr Reddy's Laboratories
Neutral
1,273.80-0.101,06,313.6318.633.140.632.34
Cipla
Moderately Bullish
1,388.800.421,12,187.3422.953.870.870.81
Mutual Fund Ownership
View all
DSP Healthcare Fund Regular Growth
NA
  • Amount Invested (Cr.) 120.90
  • % of AUM 4.08
Aditya Birla Sun Life Retirement Fund - The 40s Pln Regular Growth
NA
  • Amount Invested (Cr.) 3.03
  • % of AUM 2.63
Edelweiss Recently Listed IPO Fund Regular Plan Growth
NA
  • Amount Invested (Cr.) 22.71
  • % of AUM 2.54
Mirae Asset Healthcare Fund Regular Growth
NA
  • Amount Invested (Cr.) 66.73
  • % of AUM 2.48
Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth
NA
  • Amount Invested (Cr.) 19.31
  • % of AUM 2.37
Sai Life Sciences Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-05-14Audited Results
2026-02-05Quarterly Results
2025-11-06Quarterly Results
2025-08-07Quarterly Results
2025-05-13Audited Results
About the company Sai Life Sciences
  • IndustryBiotechnology & Drugs
  • ISININE570L01029
  • BSE Code544306
  • NSE CodeSAILIFE
Sai Life Sciences Limited is an India-based contract research, development, and manufacturing organization (CRO/CDMO). The Company carries out contract research and manufacturing activities for customers engaged in pharmaceutical and biotechnology industries. It is engaged in offering a range of services tailor-made to the customer's requirements. It provides discovery and chemistry, manufacturing, and controls (CMC) services that span from drug discovery to process development and early-phase supplies, all the way to commercial launch and life cycle management. Its services include Integrated Drug Discovery, Synthetic & medicinal chemistry, Biology, drug metabolism and pharmacokinetics (DMPK), Genotoxicity, General Toxicology and Computational chemistry. Its CMC services include route scouting; process development; analytical development; process safety; stability studies; early and mid-phase supplies; late phase, commercial manufacturing; technology transfer, and technologies.
  • Management Info
  • Krishnam KanumuriChief Executive Officer, Managing Director (Promoter)
  • Sivaramakrishnan ChittorChief Financial Officer, Additional Director
  • Kanumuri RajuWhole-Time Director (Promoter)
  • Runa KaranCompany Secretary
Sai Life Sciences Share Price FAQs

Sai Life Sciences is trading at 1218.90 as on Fri Jun 12 2026 10:10:24. This is 3.27% upper as compared to its previous closing price of 1180.30.

The market capitalization of Sai Life Sciences is 25643.97 Cr as on Fri Jun 12 2026 10:10:24.

The average broker rating on Sai Life Sciences is Strong Buy. The breakup of analyst rating is given below -

  • 2 analysts have given a strong buy rating
  • 2 analysts have given a buy rating
  • 0.00 analysts have given a hold rating
  • 0.00 analysts have given a sell rating
  • 0.00 analysts have given a strong sell rating

The 52 wk high for Sai Life Sciences is 1239.35 whereas the 52 wk low is 704.45

Sai Life Sciences can be analyzed on the following key metrics -

  • TTM P/E: 58.52
  • Sector P/E: -
  • Dividend Yield: 0.00%
  • D/E ratio: 0.12

Sai Life Sciences reported a net profit of 348.91 Cr in 2026.

The Mutual Fund Shareholding was 27.80% at the end of 31 Mar 2026.